by Ben Rogers | Jan 25, 2012 | News
Subsequent to a recent AQIS Audit Maverick has been granted Intermediate Products listing to the EU. Approval was granted 25th January 2012.
by Ben Rogers | Jan 10, 2012 | News
Maverick recently received an audit by Australian Quarantine Inspection Services (AQIS) personnel with regard to attaining listing as an exporter of “intermediate Products” to the EU. Listing is expected within the month, therefore easing constraints on...
by Ben Rogers | Aug 16, 2011 | Biomaterials, News
Maverick Biomaterials is continuing to advance its IP portfolio with regard to 3 Dimensional (3D) fixation of specifically sourced raw pericardium from it supplier Maverick Biosciences. Recent production for a range of global clients has been well received, with...
by Ben Rogers | Jan 27, 2011 | Biomaterials, News
13th January 2011, Maverick Biosciences Limited and Maverick Biosciences (NZ) Limited today received a surveillance audit by Det Norske Veritas. There were no ‘Non Conformities’ found in either minor or major categories, 1 observation was noted. The...
by Ben Rogers | Jan 11, 2010 | Biomaterials, News
11th January 2010. Maverick Biosciences Pty Limited and Maverick Biosciences (NZ) Limited was today awarded ISO.9001:2008 certification by Det Norske Veritas, valid until 2013. It has been a very pleasing outcome in that our investment in a Quality Management...
by Ben Rogers | Jun 10, 2009 | Biomaterials, News
In June 2009 Maverick commenced a 3 month trial production of pericardium against very tightly defined specifications, targeting achievement of a significant increase in the overall yields experienced by our manufacturing client. Mavericks remote production team has...
